MEC Plus

Cancer Demographics in Puerto Rico
Cancer Demographics in Puerto Rico
Marcia Cruz-Correa, MD, PhD
Diabetes Management in the Face of Healthcare Disparities
Diabetes Management in the Face of Healthcare Disparities
Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM
Neurology Drug Update
Neurology Drug Update
Nicole Quiles Alves, PharmD, RPh, MPH & Hector J. Hernandez, PharmD, MPH, CSP
Renal Cell Cancer Updates in 2024
Renal Cell Cancer Updates in 2024
https://member.mymedflix.com/wp-content/uploads/2024/07/Renal-Cell-Cancer-Updates-in-2024.png
B-Cell NHL (Low-Grades)
B-Cell NHL (Low-Grades)
Loretta Nastoupil, MD
B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)
B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)
Julio C. Chavez, MD
Myelodysplasia: De Novo and Acquired- What To Do?
Myelodysplasia: De Novo and Acquired- What To Do?
Guillermo Garcia-Manero, MD
Acute Myeloid Leukemia
Acute Myeloid Leukemia
Catherine Lai, MD
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Javier Pinilla-Ibarz, MD
Updates in Waldenstrom’s Macroglobulinemia
Updates in Waldenstrom’s Macroglobulinemia
Jorge Castillo, MD
Novel Advances in Multiple Myeloma as Front-Line Therapy
Novel Advances in Multiple Myeloma as Front-Line Therapy
Ivan M. Borrello, MD
New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?
New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?
Bruna Pellini, MD
Small Cell Lung Cancer
Small Cell Lung Cancer
Jason Porter, MD
Bi-Specific Inhibitor & ADC in Lung Cancer
Bi-Specific Inhibitor & ADC in Lung Cancer
Chul Kim, MD, MPH
Immunotherapy in NSCLC: First Line for Advanced Disease
Immunotherapy in NSCLC: First Line for Advanced Disease
Balazs Halmos, MD, MS
Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors
Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors
Edgardo S. Santos, MD, FACP